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CAA: cerebral amyloid angiopathy, CMBs: cerebral microbleeds, GRASE: gradient and spin echo, ICH: 
intracranial haemorrhage, IS: ischaemic stroke, SWI: susceptibility weighted imaging, T2*GRE: T2* 
gradient echo, TIA: transient ischaemic attack 
Introduction 
There are more than 100,000 strokes in the UK each year,1,2 with stroke being the second 
biggest killer in the world.3 Stroke is broadly classified into two groups: Ischaemic stroke (IS) or 
intracranial haemorrhage (ICH).4 The National Institute for Health and Care Excellence (NICE) 
emphasise the importance of distinguishing between these two forms of stroke for treatment 
and patient management purposes.5  
Treatment options for stroke are time and case sensitive. Ischaemic stroke may require 
thrombolysis drug therapy or mechanical thrombectomy.6-8 Intracranial haemorrhage treatment 
may include neurosurgery to relieve intracranial pressure and drug therapy to reverse the 
effects of blood-thinning medication being taken.9 Transient ischaemic attack (TIA) (minor 
stroke) comes under the umbrella term of IS, and also needs to be diagnosed for management 
proposes to prevent a future full stroke.10,11 Risk factors for stroke include arterial hypertension, 
atrial fibrillation and previous history of stroke/TIA. Individuals at high risk of IS or TIA are often 
given anticoagulation medication.12 One of the risks regarding anticoagulation is its 
unpredictable nature and its ability to cause a secondary ICH.13 
In recent years, the advantages of diagnosing cerebral microbleeds (CMBs) in acute stroke 
patients have become apparent. CMBs are small focal areas (<5mm) of chronic blood products 
(mainly hemosiderin) found in otherwise normal brain tissue.14 There are many terms used to 
describe CMBs, including:  microhaemorrhages, cerebral amyloid angiopathy (CAA),15  
superficial siderosis,16 hemosiderin deposits,14 or hypertensive arteriopathy.15 The detection of 
CMBs in acute stroke patients can affect two main areas: the stroke prognosis (and future 
stroke risk) and the consideration of drug therapies prescribed in stroke. Anticoagulant drugs 
used to prevent secondary strokes, and thrombolysis treatment used in acute IS could result in 
an even higher risk of secondary ICH in those with CMBs.17,18 Also, great care should be taken 
to control blood pressures in those with CMBs having had an ICH. The likelihood of ICH can be 
reduced by 77% in patients with established CMBs, who are actively treated with 
antihypertensive drugs than those not treated.19,20 
 CMBs can optimally be detected using magnetic resonance imaging (MRI) T2* gradient echo 
sequences (T2*GRE) or MRI susceptibility weighted imaging (SWI).21,22 Using T2*GRE MRI at 
magnetic field strengths of 1.0T & 1.5T, CMBs have been demonstrated to naturally occur in 3-
6% of the healthy elderly population,23,24 but this can increase up to 74% in those with 







Computed Tomography (CT) and MRI are routinely used to determine stroke type in those 
suspected of an acute stroke. A typical acute stroke MRI protocol may include: 1) an anatomical  
T2/FLAIR sequence, 2) a blood sensitive sequence for the detection of haemorrhage and blood 
products as well as of CMBs (this can often be a T2* or SWI sequence), a diffusion sequence 
for the early detection of ischemic and salvageable brain tissue (35).  Perfusion imaging and MR 
angiography can sometimes also be used. This 30-minute protocol can provide reliable 
information about the type of stroke, laterality of vessel occlusion, the extent of potentially 
salvageable brain tissue, and the exclusion of differential diagnoses of ischemic stroke (36). 
 Ideally, imaging protocols can detect CMBs at the same time as investigating stroke. Different 
national guidelines clearly state patient imaging pathways for suspected stroke (table 1), 
however the combination of MRI sequences to be used can be less specific or standardised and 
is summarised in table 2. MRI sequences differ between clinical sites as every site uses 
protocols available to them in an optimal way for early diagnosis.      
Not all suspected stroke patients are scanned routinely with either a T2*GRE sequence or SWI. 
if these protocols are omitted, then CMB depiction might be compromised on MRI scans and its 
incidence may be considerably lower than that suggested in the literature.   
     Table 1. UK guidelines for acute stroke imaging. All TIA MRI imaging is within 24 hours of symptom 
onset for those at high risk of developing a full stroke, and within 7 days for those at low risk. For acute 
stroke, CT & MRI can be used interchangeably depending on individual stroke unit resources. DoH= 
Department of health, SoR= Society of Radiographers, DWI= Diffusion weighted imaging. 
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• When CT 
diagnosis 
unclear. 
SoR (2015)27 • ‘Brain imaging’ immediately for 
time-sensitive treatment. 
• ‘Brain imaging’ as soon as 
possible when time-sensitive 
treatment is not a possibility. 
• No (unless MRI 
is 
contraindicated) 






Table 2. A list of suggested MRI sequences to be used in acute stroke imaging according to UK based 
literature. Y= Yes/suggested, N= No/not suggested. The need for diffusion weighted imaging (DWI) and 
T2*GRE/SWI imaging is common in all literature. T2SE= T2 spin echo, FLAIR= fluid attenuated inversion 
recovery. 
 
Authors DWI T2SE T2*GRE/SWI FLAIR 
Mair & Wardlaw 
(2014)28 
 



















Leiva Salinas and 
wintermark (2010)36 
 






















The purpose of the study was to explore the use and application of blood sensitive MR 
sequences for the detection of CMBs, with the intention of improving local practice. This study 
will particularly explore the importance of T2*GRE imaging in the detection of CMBs in 









Design, setting and ethical approval 
This retrospective research quality improvement study was conducted in an acute specialist 
stroke unit within the UK. Ethical approval was obtained from the unit’s clinical effectiveness unit 
(3 May 2019) prior to the study commencing. 
 
Equipment used and imaging sequences in retrospective analysis 
A sample of anonymised MRI brain scans performed over a consecutive 6 month period 
(January 2018-June 2018) at a single UK acute stroke centre was used. All cases were 
scanned using a 1.5 tesla scanner (Phillips, Achieva, Eindhoven, The Netherlands) and patients 
were all imaged for suspected stroke. Only those scanned with the SENSE NeuroVascular (NV) 
coil and SENSE head coil were included for parity of image quality. Equipment and imaging 
protocol details were identified and recorded through the picture archiving and communication 
system (PACS). 
The routine protocol for suspected stroke imaging at the study site includes diffusion weighted 
imaging (DWI) and gradient-and-spin echo (GRASE) sequences.  
DWI is essential for infarct detection.28-30 GRASE is a blood-sensitive sequence for 
haemorrhage detection31 and T2*GRE is for CMB detection (and confirms ICH).21 
Additionally, T1, T2 spin echo (T2SE) and fluid attenuated inversion recovery (T2 FLAIR) are 
acquired when other pathology mimicking stroke is suspected.28-30 In our site a T2*GRE is 
performed upon request by the stroke physician on call (SPOC) or when there is suspicion of 
ICH on previous imaging  sequences. 
Cases only having had DWI, had insufficient data to be included in the analysis, so were 
automatically excluded. 
 
Data review methods, inclusion and exclusion criteria 
The local radiology computer system (Soliton Radiology+, Felden, UK) was employed to review 
and identify all acute stroke cases of brain MRI within the six-month period. The imaging report 






diagnosis had been made. Table 3a lists the full inclusion and exclusion criteria for the MRI data 
review. Table 3b includes the key scan parameters of the used MRI protocols at our clinical site. 
Table 3a. Full inclusion and exclusion criteria for MRI brain scans used for data review. MRI coils and 
sequences were established using the picture archiving communication system (PACS). NA= not 
applicable. 
 Inclusion Exclusion 
Date of MRI  01.01.2018 to 30.06.2018 Any other date 
Demographics All ages, genders, races NA 
Clinical 
Indications 
Suspected stroke at time of MRI Known stroke at time of MRI 
Diagnosis Acute stroke Chronic stroke, no stroke, other 
pathology 
Patient Pathway Resus, TIA clinic, stroke ward Any other pathway 
MRI First MRI since symptom onset Previous MRI for same 
symptoms/follow up MRI scan 
MRI coils used SENSE NV coil, SENSE head 
coil 
SENSE Flex-L coil 
MRI sequences DWI with GRASE and/or 
T2*GRE, T1, T2SE and/or T2 
FLAIR 
DWI only 
Image quality Diagnostic, no artefacts Artefacts (motion, metal, etc). 
 
Table 3b : key scan parameters of the used MRI protocols at this clinical site. 















DWI 100 3666 5 240 0:44 Infarct 





23 703 5 240 3:37 ICH, CMBs 
Routine 
brain 
T1 15 672 4 240 2:32 ‘other pathology’ 
T2 120 5850 5 230 1:56 ICH, ‘other 
pathology’. 









Data analysis methods 
Having established the cases suitable for analysis, the radiology reports were also qualitatively 
reviewed for a CMB diagnosis, looking also for alternative CMB terminologies as described 
earlier.. The terminology used for CMB diagnosis in each positive case was recorded. Microsoft 
excel was used to record, review and analyse data. For quantitative analysis descriptive 
statistics was used. In addition, the qualitative relationship between CMB detection on the 
radiology report, and the use of a T2*GRE sequence in the imaging protocol was also 
examined. CMB detection rates were reported for each stroke category. 
 
Results 
In the 6-month period, 281 acute stroke patients meeting the inclusion criteria (table 3), 
attended for MRI brain imaging. Of those 113 (40.21%) were female and 168 (59.79%) were 
male (median age range 72 years, age range of 27-97 years). Of the initial sample size 259 
(92.17%) had an ischaemic stroke, 16 (5.69%) had an ICH and 6 (2.14%) had both ischaemic 
stroke and ICH (haemorrhagic transformation). Thirteen (4.63%) of the total 281 patients, had a 
diagnosis of CMBs (table 4). Table 4 summarises the total number of cases for each diagnosis. 
Figure 1 (A,B,C and D) shows the percentage of total number of stroke (and CMB) cases in 
relation to age group and gender.    
 
Table 4. Summary of acute stroke cases, and the number of cerebral microbleed cases within this acute 
stroke population (N= 281).   
Diagnosis Total Number of Cases Number of Cases (%) 
Intracranial Haemorrhage 16 5.69 
Ischaemic Stroke 259 92.17 
Both IS with ICH 
 
6 2.14 



























































































































Figure 1. Percentage number of cases for stroke and CMB diagnosis in each age group and 
gender. A= ischaemic stroke cases, B= intracranial haemorrhage cases, C= both (IS & ICH), 




The terminology used in diagnosing these 13 CMBs cases, as present in the radiologists’ report, 
is summarised in table 5. Of these 13 patients, 100% had a T2*GRE sequence. None of the 
other 268 patients (without T2*GRE) had a diagnosis of CMBs (figure 2). Eight of 259 acute IS 
cases had CMBs (3.09%) whereas 3 of 16 acute ICH cases (18.75%) had CMBs. Two of the 6 
cases with both IS and ICH had CMBs (33.33%). Of the13 CMB cases, 2 were from the TIA 































































Table 5. Terminology used to diagnose CMBs, and the number of cases in each group. 
Terminology Number of Cases (N= 13) 
CMBs 6 
CAA 1 
CMBs & CAA 2 
Superficial Siderosis 1 
Superficial Siderosis & CAA 1 

































CMB Detection Rate Comparison
Ischaemic Stroke Intracranial Haemorrhage
Figure 2. Cases of CMBs detected in those with an acute IS (3.09%) or acute ICH (18.75%), with a 
T2*GRE sequence (middle of this graph) and without a T2*GRE sequence (far right of this graph). 
Total number of cases: IS= 259, ICH= 16. These have been compared to literature based CMB 







Figure 3. Percentage of CMB cases from each patient pathway. The majority of CMB cases (and T2*GRE 
imaging) occurred in those referred from the stroke ward. N= 13.  
 
Also, to note, of the 22 patients with an identified ICH, 3 (13.64%) did not have a T2*GRE 
sequence incorporated by the radiographer. There were also 5 cases where the SPOC had 
requested a T2*GRE but it had not been completed. One of these returned at a later date to 
have T2*GRE imaging.  
 
Discussion 
MRI protocols/sequences for suspected acute stroke 
Acute stroke imaging pathways/protocols at the study site are in accordance with UK imaging 
guidelines (table 1). The MRI sequences completed at the study site, are in accordance with 
NICE (2019)6 guidelines, as DWI and a blood sensitive sequence are routinely completed.  
Although GRASE, a hybrid gradient echo and spin echo sequence, is not widely used as a 
blood sensitive brain sequence, and there is sparse literature supporting its use in stroke 
imaging, research has shown it can be as sensitive as T2SE for ICH lesions in stroke imaging.31 
This is the preferred sequence for stroke imaging at the study site because of its time efficiency 
compared to separately scanning both T2SE and T2*GRE sequences, which has certain 












susceptibility and chemical shift artefacts and lower specific absorption rate (SAR) than other T2 
sequences, as it brings together the benefits of gradient echo and spin echo imaging.32 
However, due to the closely spaced 180˚ refocussing pulses and blurring in the phase-encoding 
direction, GRASE is not as good at detecting small haemorrhagic lesions (CMBs) as T2*GRE or 
SWI sequences.33 This has been demonstrated by the results of the data analysis that found 
CMBs were only detected with T2*GRE sequences and never with GRASE imaging alone 
(figures 2 and 4).  
   
   
 
Figure 4. Example images from the stroke protocol performed at the study site. Images A & D- DWI, B 
& E, GRASE, C & F- T2*GRE. Images A to C- on a 46 year old female patient with a large area of 
restricted diffusion on the left side of the brain. CMBs present (arrow). Images D to F- 76 year old male 
patient with multiple haematomas seen throughout both cerebral hemispheres. Several CMBs seen 
(arrows). CMBs only deliniated on T2*GRE sequences.  
 
The retrospective data analysis has demonstrated the need for true T2*GRE imaging for CMB 
detection. No cases of CMBs were detected in patients without a T2*GRE sequence (figure 2). 


















literature24 (figure 2),where CMBs are present in 34% of IS patients and 60% in ICH24. This 
would suggest cases of CMBs are being missed due to the lack of T2*GRE imaging for all acute 
stroke patients. CMBs cannot be considered in important clinical decision making and patient 
management if they are undetected.   
As a true T2*GRE (or SWI) sequence is not currently routinely completed for all suspected 
acute stroke patients, the data analysis found that of the 22 patients with an identified ICH (16 
ICH cases, plus 6 cases of ICH with IS), 3 (13.64%) did not have a true T2*GRE sequence 
added by the radiographer, as described above in results, including five cases requested by the 
SPOC. When a T2*GRE referral is missed, patients can attend at a later date for this imaging 
protocol, however this may be unsettling for patients and their families but is also ineffective for 
imaging department workflows. Furthermore, stroke patient management is time-sensitive so 
important treatments might be inadvertently delayed. It is important that local policies explicitly 
state that all suspected acute stroke patients should have T2*GRE included for stroke imaging, 
to prevent a looser interpretation of formal stroke guidelines. 
The majority of CMB cases were detected in stroke ward patients rather than those from resus 
or the TIA clinic (figure 3). This may be attributed to length of time spent in clinical care. 
Clinicians have more time to discuss medical history and access patients’ notes once a patient 
is admitted to a ward. The requesting clinician may have longer to consider the likelihood of 
CMBs (ie cardiac history) and request a T2*GRE sequence. However if T2*GRE was a routine 
protocol, CMBs would be detected irrespective of patient pathway.  
 
Study limitations 
One limitation of doing a retrospective data analysis is there is no guarantee reporting 
radiologists reported on all CMB cases seen. A prospective study requiring radiologists to 
specifically report on CMBs (using specific terminology) would better guarantee CMB incidence 
rates. CMBs may not have been considered of clinical significance in an acute setting.  
There are also several medical terms for characterising CMBs (table 5). If Table 5 is not a full 







Sample size was representative and inclusive of a period of 6 months; however a larger sample 
size of 12 months might have allowed for more variability in the data and could have supported 
more conclusive results. 
Finally the SWI sequence is not readily available at all clinical sites due to scanner 
compatibilities and resource rationalisation. Therefore more focus was drawn in this paper on 
the T2*GRE sequence, as it is a frequently available blood sensitive sequence at different 
clinical sites. 
 
Recommendations for practice 
Cerebral microbleed detection in acute stroke can play an important role in clinical decision 
making with regards to the medical management of stroke. Therefore T2*GRE (or SWI) imaging 
should be completed on all suspected stroke patients that undergo MRI. Even though the NHS 
must consider time and cost as well as diagnostic accuracy, this suggest indicates that including 
a T2*GRE acquisition rather than a GRASE or T2SE alone, can increase the detection of CMBs. 
A routine T2*GRE sequence means irrespective of patient pathway, SPOC request or 
radiographer initiative in the presence of ICH on previous imaging protocols, each patient has 
equal chance of getting a CMB diagnosis, that can be considered for clinical decision making.  
If available, SWI should be the sequence of choice with regards to CMB detection. Its sensitivity 
and acquisition speed (2-4mins) make it the ideal sequence.34 If SWI is not available, as in this 
study, T2*GRE should be considered as the most appropriate sequence for CMB detection.  
Whether SWI or T2*GRE imaging is used to detect CMBs, both must be used in conjunction 
with a T2SE sequence. This is to confirm ICH diagnoses and to differentiate from stroke-
mimicking pathology.  
Suggested sequence acquisition order for stroke imaging could be; 1) DWI (for infarct & ICH), 2) 
T2*GRE (for ICH & CMBs), 3) T2SE (for ICH & stroke-mimics) and finally 4) T2 FLAIR (for ICH 
& stroke-mimics, if locally deemed necessary). This ensures the most clinically useful 
sequences for stroke detection are performed first incase the patient becomes agitated and un-






All stroke unit reporting radiologists must be made aware of the importance of a CMB diagnosis 
in acute stroke. Radiologists, and stroke clinicians, should be provided with a universal list of 
CMB terms to be used in reporting. Currently there are several terms being used (table 5). This 
would ensure all cases of CMBs would be officially diagnosed.  
 
Conclusion 
For patients undergoing MRI for suspected acute ischaemic stroke certain sequences may be 
beneficial for the timely and accurate detection of CMBs. If a SWI sequence is unavailable, 
T2*GRE imaging must be included. The detection of CMBs should be used as it may inform 
clinical decision making with regards to patient management. 
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